US › Healthcare

Accendra Health Inc (ACH)

US · Healthcare · Medical Distribution

$2.94-13.78%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$627.8M
Revenue YoY
-76.1%
Net profit
$-6.5M
Profit YoY
+74.1%
EPS
$-0.04
EPS estimate
$-0.10
Net margin
-1.0%

EPS came in at -0.04 against a street estimate of -0.10 — a beat of 60.0%.

Key statistics

Market cap
$240.5M
Forward P/E
2.9
P/B
1.07
Book value
$-6.07
EPS (TTM)
$-1.37
52-week high
$7.10
52-week low
$1.84
50-day MA
$3.14
200-day MA
$2.97
Beta
1.58

Analyst view

with an average price target of $4.39.

Shareholding

Insiders
7.71%
Institutions
85.75%

Largest institutional holders

FundStake
Coliseum Capital Management LLC17.11%
BlackRock Inc6.84%
Charles Schwab Investment Management Inc4.75%
Bank of America Corp4.45%
Invenomic Capital Management, LP4.40%
D. E. Shaw & Co LP4.32%
Vanguard Capital Management, LLC4.29%
Vanguard Portfolio Management, LLC3.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Accendra Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.